Delivery Order SPE2DB22D3019-SPE2DB25FK4AW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,186.02 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,616.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count packages). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award to the established pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $17,049.73 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,969.07 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $5,898.94. This firm fixed-price delivery order is scheduled for ultimate completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,481.14 for Progesterone 200 mg capsules (100 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $19,358.34 delivery order to AmerisourceBergen Drug Corp for 100 units of Progesterone 200 mg capsules under a firm fixed-price contract, with an ultimate completion date of August 19, 2025. This non-set-aside award was issued on August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $1,043.85. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count) under a firm fixed price contract valued at $26,680.56, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,473.92 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4AWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $29,014 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive procurement requiring delivery to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical supply needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition, combined with its extensive portfolio across multiple therapeutic domains, positions it as a key supplier within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.0k | 8/6/25 |